The retinoblastoma tumour suppressor in development and cancer
The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Abstract
Since its discovery, the retinoblastoma (RB) tumour-suppressor protein has been a focal point of cancer research. Accumulating evidence indicates a complex role for RB in cell proliferation, differentiation and survival. To further complicate matters, proteins that are related to RB have redundant as well as antagonistic functions. Recent studies of knockout mice and cells that lack one or more of these proteins have begun to clarify their various context-specific functions and the unique activity of this tumour suppressor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The role of RB in promoting cellular differentiation during embryonic development and in adult lineages has been well characterized in mutant mice and in vitro systems20,42,58–61.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [61]
In the citing paper
“The growth suppressive properties of Rb are largely, but not completely, associated with its binding to the transcription factor E2F and repressing transcription at target promoters (Classon and Harlow, 2002; Harbour and Dean, 2000; Stevaux and Dyson, 2002).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Classon and Harlow, 2002
In the citing paper
“In virtually all human cancer cells, this circuit is dysregulated by either overexpression of cyclin D1, loss of p16Ink4a, the mutation of CDK4 to an Ink4-refractory state, or the loss of Rb itself (Classon and Harlow, 2002).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Classon and Harlow, 2002
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“RB is therefore linked directly to the intricate regulatory network that controls cell-cycle progressio”
BackgroundA human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459 · cited 1×
“These findings indicated that RB is a regulator of cell proliferatio”
BackgroundHuman Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Self-citationMice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
Research works printed but not linked: 4
- Guo, Z., Yikang, S., Yoshida, H., Mak, T. W. & Zacksenhaus, E. Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61, 8395–8400 (2001).
- Guo, Z., Yikang, S., Yoshida, H., Mak, T. & Zacksenhaus, E. Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61, 8395–8400 (2001).
- Vooijs, M. & Berns, A. Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 18, 5293–5303 (1999). · DOI
- Elliott, M. J., Dong, Y. B., Yang, H. & McMasters, K. M. E2F-1 upregulates c-Myc and p14ARF and induces apoptosis in colon cancer cells. Clin. Cancer Res. 7, 3590–3597 (2001).
Cited by
Items 401–500 of 738
T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo
Klein, K., Witalisz‐Siepracka, A., Gotthardt, D., Agerer, B., Sternberg, F., Grausenburger, R., Knab, V. M., Bergthaler, A., & Sexl, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650977 · Cited by 19
Asghar, A., Chohan, T. A., Khurshid, U., Saleem, H., Mustafa, M. W., Khursheed, A., Alafnan, A. D., Batul, R., Break, M. K. B., Almansour, K., et al. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.110940 · Cited by 18
Strategy of combining CDK4/6 inhibitors with other therapies and mechanisms of resistance
Xue, Y., & Zhai, J. (2024) · International Journal of Clinical and Experimental Pathology · doi:10.62347/hgni4903 · Cited by 20
Non-Coding RNAs in Pediatric Solid Tumors
Smith, C. M., Catchpoole, D. R., & Hutvágner, G. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00798 · Cited by 18
Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle
Yang, J., Li, Y., Zong, C., Zhang, Q., Ge, S., Ma, L., Fan, J., Zhang, J., & Jia, R. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.15.11 · Cited by 19
FGF2 and Insulin Signaling Converge to Regulate Cyclin D Expression in Multipotent Neural Stem Cells
Adepoju, A., Micali, N., Ogawa, K., Hoeppner, D. J., & McKay, R. D. G. (2013) · Stem Cells · doi:10.1002/stem.1575 · Cited by 20
Acharya, P., Raj, N., Buckley, M. S., Zhang, L., Duperon, S., Williams, G. L., Henry, R. W., & Arnosti, D. N. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-06-0520 · Cited by 19
“RB is also inactivated in a significant proportion of adult onset human cancers (Knudson, 1978; Classon and Harlow, 2002) attesting to the centrally important role for RB in proliferation control.”
BackgroundHughes, T. A., & Brady, H. J. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.102 · Cited by 21
Conway, R. M., WHEELER, S., MURRAY, T., Jockovich, M. E., & OBRIEN, J. (2005) · Ophthalmology Clinics of North America · doi:10.1016/j.ohc.2004.08.006 · Cited by 19
“These findings support a critical role for pRb in tissue differentiation in latter stages of development [26].”
BackgroundNovel Approaches for Chemosensitization of Breast Cancer Cells: The E1A Story
Liao, Y., Yu, D., & Hung, M. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74039-3_11 · Cited by 20
TRPM2 regulates cell cycle through the Ca2+-CaM-CaMKII signaling pathway to promote HCC
Cai, X., Yu, X., Yang, J., Lu, L., Hua, N., Duan, X., Ye, P., Ni, L., Jiang, L., Yang, W., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000101 · Cited by 19
RB functions as a key regulator of senescence and tumor suppression
Gao, M., Li, H., & Zhang, J. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.004 · Cited by 22
RB gene family: Genome‐wide ChIP approaches could open undiscovered roads
Rizzolio, F., Esposito, L., Muresu, D., Fratamico, R., Jaraha, R., Caprioli, G. V., & Giordano, A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22448 · Cited by 20
“Examples of differences include their expression pattern, E2F family member interaction (p107 and Rb2/p130 interact with E2F4/5 (repressing E2Fs) and pRb interacts with E2F13 (activating E2Fs)), cyclin/cdk complexes [Nevins, 1998; Classon and Dyson, 2001; Classon and Harlow, 2002; Cobrinik, 2005] and sets of target ge…”
BackgroundMammalian Cochlear Hair Cell Regeneration and Ribbon Synapse Reformation
Lu, X., Shu, Y., Tang, M., & Li, H. (2016) · Neural Plasticity · doi:10.1155/2016/2523458 · Cited by 19
Li, M., Song, X., Jin, Q., Chen, Y.-S., Zhang, J., Gao, J., Cen, L., Lin, Y.-M., Xu, C.-F., He, X., et al. (2022) · Liver international (Print) · doi:10.1111/liv.15228 · Cited by 16
Shackney, S. E., Chowdhury, S. A., & Schwartz, R. S. (2014) · Cancer Informatics · doi:10.4137/cin.s14062 · Cited by 17
Rb and hematopoiesis: stem cells to anemia
Walkley, C. R., Sankaran, V. G., & Orkin, S. H. (2008) · Cell Division · doi:10.1186/1747-1028-3-13 · Cited by 21
“Since it is known that G1 exit frequently requires the activity of Rb to occur in other cell types [63,91], it is important to understand the role that this gene plays in the process of erythropoiesis.”
Doi, K., Takeuchi, H., & Sakurai, H. (2022) · FEBS Journal · doi:10.1111/febs.16612 · Cited by 17
Kalderon, D. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_8 · Cited by 17
Lee, H., Ragusano, L., Martinez, A., Gill, J., & Dimova, D. K. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06314-11 · Cited by 18
“The E2F and RB families of transcription factors are critical regulators of these processes, and E2F/RB activity is altered in many human tumors (5, 7, 9, 31, 40).”
BackgroundLiu, Y., Liu, Y., Zheng, X. S., Zhao, L., & Zhang, X. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901713 · Cited by 16
Bassiouny, A. E. E., Nosseir, M. M. F., Zoheiry, M. K., Ameen, N. A., Hadi, A. M. A., Ibrahim, I. M., Zada, S. K., El-Deen, A.-H. S., & El-Bassiouni, N. E. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i1.32 · Cited by 15
Retinoblastoma RB94 Enhances Radiation Treatment of Head and Neck Squamous Cell Carcinoma
Araki, K., Ahmad, S. M., Li, G., Bray, D. A., Saito, K., Wang, D., Wirtz, U., Sreedharan, S. P., O'Malley, B. W., & Li, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4538 · Cited by 19
Effect of Recql5 deficiency on the intestinal tumor susceptibility ofApcminmice
Hu, Y., Lu, X., & Luo, G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i12.1482 · Cited by 19
Histone deacetylase inhibitors potentiate photochemotherapy in cutaneous T-cell lymphoma MyLa cells
Sung, J. J., Ververis, K., & Karagiannis, T. C. (2014) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2014.01.009 · Cited by 18
“arrest in G1 or G2/M phase through dysregulation of proteins, which mediate cell cycle progression and coordinate G1/S and G2/M transition, such as cyclins and cyclin-dependent kinases [39-41].”
BackgroundEffects of Granulosa Cell-Specific Deletion of Rb in Inha-α Null Female Mice
Andreu‐Vieyra, C., Chen, R., & Matzuk, M. M. (2007) · Endocrinology · doi:10.1210/en.2006-1590 · Cited by 16
Gu, Y., Zhang, X., Yu, W., & Dong, W. (2022) · Journal of Cancer · doi:10.7150/jca.57663 · Cited by 18
“The retinoblastoma tumor suppressor protein (pRb) functions as a hub in the regulatory network orchestrating cell proliferation, differentiation, and survival [94].”
BackgroundHuang, H., Fu, Y., Zhang, Y., Peng, F., Lu, M., Feng, Y., Chen, L., Chen, Z., Li, M., & Chen, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.577784 · Cited by 13
Progressing from Gene Mutations to Cancer
Fearon, E. R., & Bommer, G. T. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50017-8 · Cited by 18
Ayaz, F., Kheeree, R., Isse, Q. A., Ersan, R. H., & Algül, Ö. (2018) · Journal of the Turkish Chemical Society Section A Chemistry · doi:10.18596/jotcsa.429504 · Cited by 15
“Tumor cells fall into this category due to their higher proliferation rate compared to the normal cells (7-15, 19-22).”
BackgroundInvestigating gene function using mouse models
Lee, D., & Threadgill, D. W. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.04.013 · Cited by 17
Murray, M. M., Terry, N. H. A., & Keyomarsi, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1809 · Cited by 16
“Such alterations in the pRb pathway lead to a deregulated cell cycle and the ability of the tumors to bypass the G1 checkpoint (8, 9).”
BackgroundThe Pivotal Roles of GSK3β in Glioma Biology
Nakada, M., Minamoto, T., Ilya, V. V., Hayashi, Y., & Ham, J.-I. (2011) · InTech eBooks · doi:10.5772/21458 · Cited by 18
“Simultaneously, the phosphorylated fraction of retinoblastoma protein (Rb) (inactive form) decreased, which associated with down-regulation of cyclin-dependent kinase 6 (CDK6) (Miyashita et al., 2009a).”
Molecular and genetic basis of childhood cancer
Rushton, J. R., & Lopez-Terrada, D. H. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0199 · Cited by 16
“However, the tumor suppressor role of RB1 is not limited to the retina, as somatic mutations in the gene are present in numerous other tumors, including small cell carcinoma of the lung and osteogenic sarcoma [234].”
Saddic, L., Wirt, S. E., Vogel, H. S., Felsher, D. W., & Sage, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019758 · Cited by 14
“emerging evidence indicates that RB also normally promotes differentiation in multiple lineages [5,6,7,8,9,10,11] and protects”
BackgroundPutta, S., Álvarez, L., Lüdtke, S., Sehr, P. A., Müller, G. A., Fernandez, S. M., Tripathi, S. M., Lewis, J., Gibson, T. J., Chemes, L. B., et al. (2022) · Structure · doi:10.1016/j.str.2022.05.019 · Cited by 19
Zhao, M., Liu, W., Zhang, X., Zhang, Y., & Luo, B. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28338 · Cited by 15
“RB is a universal cell cycle regulator that plays a central role in controlling initiation of DNA replication and cell division.(14) RB exerts its tumor suppressor activity by binding to E2F transcription factors”
BackgroundWei, Y., Mondal, S. S., Mouawad, R., Wilczyński, B., Henry, R. W., & Arnosti, D. N. (2015) · G3 Genes Genomes Genetics · doi:10.1534/g3.115.019166 · Cited by 15
Su, H., Chang, J., Xu, M., Sun, R., & Wang, J. (2019) · Oncology Reports · doi:10.3892/or.2019.7144 · Cited by 14
McLear, J. A., Garcia‐Fresco, G. P., Bhat, M. A., & Dyke, T. A. V. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.07.012 · Cited by 18
Steele, L. J., SUKHANOVA, M. J., Xu, J., Gordon, G. M., Huang, Y., Yu, L., & Du, W. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.09.004 · Cited by 14
“The retinoblastoma protein pRb is a prototype tumor suppressor that is often mutated or inactivated in cancers (Classon and Harlow, 2002; Weinberg, 1995).”
BackgroundMukherjee, S., Manna, S., Pal, D., Mukherjee, P., & Panda, C. K. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22089 · Cited by 15
“An essential step through G1/S phase is the sequential phosphorylation of Retinoblastoma (pRb) by different CyclinCdk complexes (Classon and Harlow, 2002; Macaluso et al., 50 M U K H E R J E E E T A L .”
BackgroundRetractedJiao, W., Lin, H., Timmons, J. C., Nagaich, A. K., Ng, S., Misteli, T., & Rane, S. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3999 · Cited by 14
“E2F1 (1-363) that retains the E2F1-specific retinoblastoma binding is as efficient in repression as WT E2F1 indicating that the E2F1-specific retinoblastoma-binding motif is sufficient for E2F1 repressor activity (Fig.”
BackgroundMethodSurprising Dependency for Retinoblastoma Protein in Ras-Mediated Tumorigenesis
DeGregori, J. V. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1165-1169.2006 · Cited by 18
“In fact, while inheritance of one mutated Rb allele results in high penetrance retinoblastoma in humans, retinoblastoma development in mice requires either mutation of both Rb and p107 or expression of viral oncoproteins that inhibit the activities of all three Rb family members (5).”
BackgroundInfluentialSantos, M., Ruiz, S., Lara, M. F., Segrelles, C., Moral, M., Martínez‐Cruz, A. B., Ballestín, C., Lorz, C., García‐Escudero, R., & Paramio, J. M. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20426 · Cited by 14
“gression, differentiation and inhibition of oncogenic transformation in multiple tissues [1].”
BackgroundPharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer
Li-zhi, C., Huang, D., Tang, Z., Zhang, J., Xiong, T., Zhou, C., Zhang, N., Fu, R., Cheng, Y., & Wu, Z. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16193 · Cited by 16
Gao, Y., Chen, L., Song, H., Chen, Y., Wang, R., & Feng, B. (2016) · Oncotarget · doi:10.18632/oncotarget.8376 · Cited by 13
“Repressor E2Fs constrain the transcription of E2F target genes when cooperate with the pocket proteins p107 and p130 and with the addition of repressive histone deacetylases during the early G1 phase [38].”
A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts
Xie, X., Bansal, N., Shaik, T., Kerrigan, J. E., Minko, T., Garbuzenko, O. B., Abali, E. E., Johnson-Farley, N. N., Banerjee, D., Scotto, K. W., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1809 · Cited by 13
Retinoblastoma major review with updates on Middle East management protocols
Othman, I. S. (2012) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2012.03.002 · Cited by 13
“Tumor virus transforming proteins (adenovirus EIA, simian virus 40 (SV40) antigen, large T and human papilloma virus [HPV-E7]) induce tumors by binding to and inactivating the active form of Rb protein.(9) Some oncoviruses (SV4O,”
BackgroundMaster or slave: The complex relationship of RBP2 and pRb
Gutierrez, G. M., Kong, E., & Hinds, P. W. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.021 · Cited by 16
Evans‐Anderson, H. J., Edwards, L., & Goodwin, R. L. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.035 · Cited by 13
“This family of proteins, which includes Rb, p107, and p130, has been implicated in the regulation of the G1/S checkpoint in the cell cycle by suppressing transcription of cell cycle-regulatory genes through phosphorylation by cyclin/CDK complexes as well as interactions with various transcription factors [20,21].”
BackgroundRoig, J. M., Molina‐Vila, M. Á., Cascante, A., Calbó, J., Carbó, N., Wirtz, U., Sreedharan, S. P., Fillat, C., & Mazo, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0442-03 · Cited by 14
“Phosphorylation in late G1, executed by members of the cyclin-dependent family of kinases, lowers RB’s affinity for transcription factors, such as E2F-1, leading to activation of genes whose products are required to enter in the S phase (23).”
BackgroundGekonge, B., Raymond, A., Yin, X., Kostman, J. R., Mounzer, K., Collman, R. G., Showe, L. C., & Montaner, L. J. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1111552 · Cited by 13
Davison, E. M., Saffer, A. M., Huang, L. S., DeModena, J. A., Sternberg, P. W., & Horvitz, H. R. (2011) · Genetics · doi:10.1534/genetics.110.124487 · Cited by 13
“…Rb (Lu and Horvitz 1998; Ceol and Horvitz 2001; Harrison et al. 2006). pRb and the related proteins p107 and p130 play critical roles in mammalian cell-cycle regulation, apoptosis, development, and differentiation (Classon and Harlow 2002), and Rb is often mutated in human cancers (Nevins 2001).”
BackgroundGhazaryan, S., Sy, C. B., Hu, T., An, X., Mohandas, N., Fu, H., Aladjem, M. I., Chang, V. T.-S., Opavský, R., & Wu, L. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01651-13 · Cited by 14
Cremona, C. A., & Lloyd, A. C. (2009) · Journal of Cell Science · doi:10.1242/jcs.047126 · Cited by 14
“Moreover, levels of many cyclin and CDK proteins were several times higher in both the NSLT and NSLTRas attached cells compared with NS cells, consistent with the derepression of their gene promoters upon inactivation of the Rb family (Classon and Harlow, 2002; Markey et al., 2007).”
BackgroundMolecular Approaches in Pediatric Oncology
Khanna, C., & Helman, L. J. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131247 · Cited by 13
Lifshagerd, M. R., & Safari, F. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-022-03067-4 · Cited by 13
“It was previously reported that growth factors are responsible to assemble and activate cyclin D and CDK4/6 [27, 28].”
BackgroundPI3K p110α Blockade Enhances Anti-Tumor Efficacy of Abemaciclib in Human Colorectal Cancer Cells
Lee, H. J., Kim, K., Sung, J. H., Nam, M., Suh, K. J., Kim, J., Kim, S. H., Kim, S. H., Kim, J. W., Lee, K., et al. (2020) · Cancers · doi:10.3390/cancers12092500 · Cited by 11
“In cancer cells, the cell cycle is dysregulated by cyclin D1 overexpression, p16 loss, CDK4 mutation, and Rb loss [4].”
Rashid, N. N., Yusof, R., & Watson, R. J. (2013) · Acta Virologica · doi:10.4149/av_2013_04_447 · Cited by 12
“…related to two genes in mice and humans (p107 and p130), which are not commonly mutated in tumors and these proteins are referred to as the pocket proteins because their main sequence similarity resides in a domain that mediates interaction with the viral oncoproteins (Classon and Harlow, 2002).”
BackgroundInfluentialHuang, W., & Wang, H. (2021) · Translational Breast Cancer Research · doi:10.21037/tbcr-20-52 · Cited by 14
“Activation of cyclin E-CDK2 complex phosphorylates Rb and activate E2F to upregulate the target gene expression, which is required for S phase (64).”
BackgroundAnalyzing RB and E2F During the G1–S Transition
Thwaites, M. J., Cecchini, M. J., & Dick, F. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_24 · Cited by 12
Advances in Cancer Stem Cell Biology
Scatena, R., Giardina, B., & Mordente, A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0809-3 · Cited by 14
Derenzini, M., Montanaro, L., Vici, M., Barbieri, S., Ceccarelli, C., Santini, D., Taffurelli, M., Martinelli, G., & Treré, D. (2007) · PubMed · doi:10.14670/hh-22.505 · Cited by 12
Jothi, M., Rohini, K., Gope, M. L., Anandh, B., & Gope, R. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9428-3 · Cited by 12
Elchuri, S. V., Rajasekaran, S., & Miles, W. O. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00170 · Cited by 15
“Inactivation of the pRB/E2F pathway is one of the hallmarks of cancer and is ubiquitously disrupted in most tumor types (Sherr, 2000; Classon and Harlow, 2002).”
BackgroundWu, Q., Berglund, A., Macaulay, R. J. B., & Etame, A. B. (2024) · Cells · doi:10.3390/cells13110942 · Cited by 13
“…is highly dysregulated in GBM through aberrations of crucial activators Hence, a deeper understanding of the nature of cellular and molecular heterogeneity in GBM is essential to developing therapies that are impactful in GBM. of p53 such as CDK4 amplification and CDKN2A deletion in GBM [55].”
BackgroundYunoki, T., Tabuchi, Y., Hayashi, A., & Kondo, T. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2874-1 · Cited by 11
Hu, X., Luo, P., Peng, X., Song, T., Zhou, Y., Wei, H., Peng, J., & Jiang, S. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.01.016 · Cited by 11
“Retinoblastoma gene 1 (Rb1), was the first known cloned tumor suppressor gene and it is functionally inactivated in most human cancers (Classon, 2002; Huang et al., 1988; Sherr and McCormick, 2002).”
BackgroundVerdugo‐Sivianes, E. M., & Carnero, A. (2021) · Cancers · doi:10.3390/cancers13092226 · Cited by 16
Li, K., Huang, G., Wang, Z., Yang, R., Zhang, W., Ni, B., Guan, J., Yi, G., Li, Z., Zhu, Q., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166571 · Cited by 14
Drinkwater, K., Anderson, B., Seangmany, N., Hampel, D., Mody, A., & Shim, M. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110509 · Cited by 11
Identifying pathways affected by cancer mutations
Iengar, P. (2017) · Genomics · doi:10.1016/j.ygeno.2017.12.004 · Cited by 11
Central Role of Cell Cycle Regulation in the Antitumoral Action of Ocoxin
Pérez‐Peña, J., Díaz-Rodríguez, E., Sanz, E., & Pandiella, A. (2019) · Nutrients · doi:10.3390/nu11051068 · Cited by 10
“E2F interaction with critical regulatory proteins such as the retinoblastoma protein, modulates the transcriptional properties of E2F [25,37,38].”
Li, J., Zhou, Y., Yan, Y., Zheng, Z., Hu, Y., & Wu, W. (2020) · Aging · doi:10.18632/aging.103537 · Cited by 15
“Abnormal Rb regulation in tumor cells manifested with overexpressed CDK4/CDK6 and the loss of p16 expression or CDK4/CDK6 mutation leading to no response to p16 [33].”
BackgroundSingh, L., Saini, N., Bakhshi, S., Pushker, N., Sen, S., Sharma, A., Kaur, J., & Kashyap, S. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.06.001 · Cited by 11
Function of the Retinoblastoma-related Protein in Plants
Gruissem, W. (2007) · Blackwell Publishing Ltd eBooks · doi:10.1002/9780470988923.ch7 · Cited by 12
Aberrant Proliferation in CXCR7+ Endothelial Cells via Degradation of the Retinoblastoma Protein
Totonchy, J. E., Osborn, J. M., Botto, S., Clepper, L., & Moses, A. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069828 · Cited by 11
“Aberrant inhibition of Rb function is a frequent occurrence in the course of human tumorigenesis [20].”
Hassink, R. J., Nakajima, H. O., Nakajima, H. O., Doevendans, P. A., & Field, L. J. (2009) · Heart · doi:10.1136/hrt.2008.150128 · Cited by 13
“For example, p107 is a member of the retinoblastoma protein gene family[14] and is thought to regulate transit through a G1/S cell cycle check point.”
BackgroundDeletion of Rb1 induces both hyperproliferation and cell death in murine germinal center B cells
He, Z., O’Neal, J., Wilson, W. C., Mahajan, N., Luo, J., Wang, Y., Su, M. Y., Lu, L., Skeath, J. B., Bhattacharya, D., et al. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.11.006 · Cited by 12
“The function of Rb1 as a tumor suppressor has been well-studied, and genetically targeted mice have been invaluable tools in dissecting the role of Rb1 in tumor development [10,11].”
BackgroundWalton, D. S., Mukai, S., Grabowski, E. F., Munzenrider, J. E., & Dryja, T. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmcpc059041 · Cited by 11
Lavernia, J., Claramunt, R., Romero, I., López‐Guerrero, J. A., Llombart-Bosch, A., & Machado, I. (2024) · Cancers · doi:10.3390/cancers16020432 · Cited by 13
Baba, R. E., & Herbein, G. (2024) · Cells · doi:10.3390/cells13060541 · Cited by 11
“The reduced potential for differentiation and heightened rates of proliferation observed in Rb-deficient cells could both play a role in tumorigenesis [49].”
BackgroundChen, Z., Yang, A., Xu, C., Xing, Y., Gong, W., & Li, J. (2011) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1607-3 · Cited by 12
“Retinoblastoma represents the prototypic model for inherited cancers [ 3 ], due to mutations or deletions of both copies of the retinoblastoma gene at the chromosomal locus 13q14 [4].”
BackgroundYunoki, T., Tabuchi, Y., Hayashi, A., & Kondo, T. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12618 · Cited by 12
Mechanisms of Gastrointestinal Malignancies
Katona, B. W., & Lynch, J. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00066-9 · Cited by 13
Comparison of PI3K Pathway in HPV‐Associated Oropharyngeal Cancer With and Without Tobacco Exposure
Kiessling, S.-Y., Broglie, M. A., Soltermann, A., Huber, G. F., & Stoeckli, S. J. (2018) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.175 · Cited by 10
Feng, Y., Yan, S., Huang, Y., Huang, Q., Wang, F., & Lei, Y. (2020) · BMC Cancer · doi:10.1186/s12885-020-07068-w · Cited by 10
“RABL6 regulated retinoblastoma 1 (Rb1) activity in osteosarcoma cells, which was the major player in cell cycle control [10, 20, 21].”
BackgroundMurray, T. G., Pina, Houston, S. S., Koru‐Sengul, T., Decatur, Nathanson, L., Clarke, J., & Lampidis (2012) · Clinical ophthalmology · doi:10.2147/opth.s29688 · Cited by 10
Sengupta, S., Lingnurkar, R., Carey, T. S., Pomaville, M. M., Kar, P., Feig, M., WILSON, C. A., Knott, J. G., Arnosti, D. N., & Henry, R. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.599993 · Cited by 13
Functional and physical communication between oncoproteins and tumor suppressors
Prochownik, E. V. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5199-8 · Cited by 11
Sharpless, N. E. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.33.pe24 · Cited by 14
The role of inner nuclear membrane protein emerin in myogenesis
Marano, N., & Holaska, J. M. (2025) · The FASEB Journal · doi:10.1096/fj.202500323 · Cited by 12
“139,140 When Rb is hyperphosphorylated by cyclin-dependent kinases (CDKs), Rb dissociates from E2F/DP, and E2F/DP-regulated genes (e.g., Cyclin E) are transcribed, allowing progression from G1-to S-phase.”
Trouth, A., Ravichandran, K., Gafken, P. R., Martire, S., Boyle, G. E., Veronezi, G. M. B., La, V. E., Namciu, S. J., Banaszynski, L. A., Sarthy, J. F., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003119 · Cited by 14
“Inactivation of retinoblastoma protein (Rb) and cyclin-dependent kinase inhibitor 2A (CDKN2A) occurs frequently in cancer [20,21].”
Fahham, N., Sardari, S., Ostad, S. N., Vaziri, B., & Ghahremani, M. H. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22892 · Cited by 12
“…of the retinoblastoma (Rb) protein by CDK4 and CDK6, blocks the activity of E2F transcription factors and the expression of genes essential for the onset of S phase and mitosis, which results in arresting the cells in the G1 phase of the cell cycle [Weinberg, 1995; Classon and Harlow, 2002].”
BackgroundPost-translational modifications of lysine-specific demethylase 1
Kim, D., Nam, H. J., & Baek, S. H. (2023) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2023.194968 · Cited by 10
Regulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer
Martin‐Caraballo, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084171 · Cited by 9
“Low-level phosphorylation of Rb1 in quiescent cells inhibits cell cycle progression, whereas mitogenic signals promote Rb1 phosphorylation and cell division [118].”
BackgroundCheng, B., Zhang, H., Liu, C., Chen, X., Chen, Y., Sun, Y., Leng, L., Li, Y., Luan, P., & Li, H. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01719 · Cited by 10
[Research Progress of CDK4/6 Inhibitors in Non-small Cell Lung Cancer].
Qin, Q., Ren, Y., & Zhong, D. (2020) · PubMed Central · doi:10.3779/j.issn.1009-3419.2020.03.07 · Cited by 9
Zhao, L., Santiago, A., Liu, J., & Liao, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610749200 · Cited by 10
Metadata
- Authors
- Classon, M., & Harlow, E.
- Affiliations
- Harvard University (US)
- ORCID
- Classon, Marie
- Venue
- Nature Reviews Cancer
- Published
- 2002-12-01
- Volume
- 2
- Issue
- 12
- Pages
- 910-917
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1998492363
- Cited by
- 738
- References
- 133
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 19 · 2023: 13 · 2022: 20 · 2021: 18 · 2020: 31 · 2019: 18 · 2018: 15 · 2017: 28 · 2016: 24 · 2015: 32 · 2014: 35 · 2013: 23 · 2012: 42
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- retinoblastoma protein, RB1, tumour suppressor, cell proliferation, cell differentiation, cell survival, Rb family proteins, protein redundancy, knockout mice, development (biology), cancer
- MeSH terms
- Animals, Cell Division, Humans, Nuclear Proteins, Phenotype, Phosphoproteins, Proteins, Retinoblastoma, Signal Transduction, Retinoblastoma Protein, Genes, Retinoblastoma, Mice, Knockout, Retinoblastoma-Like Protein p130, Retinoblastoma-Like Protein p107, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.